Sterigmatocystine is a precursor of aflatoxins and a mycotoxin produced by common mold strains from Aspergillus versicolor. Sterigmatocystine, a inhibitor of G1 Phase and DNA synthesis, is used to inhibit p21 activity. Sterigmatocystine has teratogenic, and carcinogenic effects in animals.
性状
Solid
IC50 & Target[1][2]
Microbial Metabolite
Human Endogenous Metabolite
体外研究(In Vitro)
Sterigmatocystine-induced DNA damage activates the ATM/53-dependent signaling pathway, which contributes to the induction of G2 arrest in GES-1 cells.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Sterigmatocystine (ip; 3 mg/kg once daily for 14 days) inhibits p21.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.